In the current trading session, Mereo Biopharma Group Plc ADR’s (MREO) stock is trading at the price of $1.92, a gain of 5.19% over last night’s close. So, the stock is trading at a price that is -61.65% less than its 52-week high of $5.02 and 11.92% better than its 52-week low of $1.72. Based on the past 30-day period, the stock price is -30.40% below the high and +10.47% above the low.
MREO’s price to book ratio for the most recent quarter was 4.90, resulting in an 4.28 price to cash per share for the period.
How does Mereo Biopharma Group Plc ADR (MREO) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 8 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 4.88 in simple terms.
Mereo Biopharma Group Plc ADR (MREO): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 3 different analysts, who are expecting earnings to fall in between the range of 0.07 and -0.09 with an average Earnings Estimate of -0.01 which is in contrast with the last year earnings estimate of -0.01 and also replicates unch growth rate year over year.
Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Ownership Details
I will give a breakdown of the key shareholders in Mereo Biopharma Group Plc ADR (MREO). Recent figures show that the company’s insiders hold 0.99% of shares. A total of 100 institutional investors hold shares in the company, making 73.11% of its stock and 73.84% of its float.
Dec 31, 2024, it was reported that the Company’s largest institutional holder is Janus Henderson Group PLC holding total of 17.12 shares that make 0.44% of the company’s total number of shares and are currently priced at 32.45 million.
The securities firm Rubric Capital Management LP holds 15.31 shares of MREO, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.39%, and the holding percentage of shares is valued at 29.01 million.
An overview of Mereo Biopharma Group Plc ADR’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Mereo Biopharma Group Plc ADR (MREO) traded 1,218,785 shares per day, with a moving average of $2.3490 and price change of -0.6100. With the moving average of $2.6038 and a price change of -1.0200, about 1,256,740 shares changed hands on average over the past 50 days. Finally, MREO’s 100-day average volume is 1,198,393 shares, alongside a moving average of $3.0492 and a price change of -2.3800.
